PVRIG

PVRIG 詳細

英語名Transmembrane protein PVRIG市販薬剤の数0
治験薬の数7ターゲットの別称PVRIG,PVR Related Immunoglobulin Domain Containing,CD112 Receptor,Poliovirus Receptor-Related Immunoglobulin Domain-Containing Protein,Poliovirus Receptor Related Immunoglobulin Domain Containing,Nectin-2 Receptor,C7orf15,CD112R,Transmembrane Protein PVRIG,MGC2463
研究&開発段階Phase 2 Clinical
英語名Transmembrane protein PVRIG
ターゲットの別称PVRIG,PVR Related Immunoglobulin Domain Containing,CD112 Receptor,Poliovirus Receptor-Related Immunoglobulin Domain-Containing Protein,Poliovirus Receptor Related Immunoglobulin Domain Containing,Nectin-2 Receptor,C7orf15,CD112R,Transmembrane Protein PVRIG,MGC2463
市販薬剤の数0
治験薬の数7
研究&開発段階Phase 2 Clinical

PVRIG 製品リスト

  • 属性

    Protein (11)

  • 製品ライブラリ

    オンライン (11)

  • Human (5)Mouse (4)Cynomolgus (2)

  • タグ

    His Tag (4)Fc Tag (3)His Tag & Avi Tag (2)Mouse IgG Fc Tag (1)Fc Tag & Avi Tag (1)

  • マーカー

    Unconjugated (8)Biotin-labeled (3)

PVRIGバックグランド

Human PVRIG (poliovirus receptor related immunoglobulin domain-containing protein), also known as CD112 receptor (CD112R), is an approximately 34 kDa single transmembrane protein in the poliovirus receptor-like protein (PVR) family. The CD112R gene encodes a putative single transmembrane protein, which is composed of a single extracellular IgV domain, one transmembrane domain, and a long intracellular domain. Notably, the intracellular domain of phatases. The extracellular domain sequence of human and mouse CD112R have 65.3% similarity. CD112R may act as a coinhibitory receptor that suppresses T-cell receptor-mediated signals.

PVRIG分子の別称

C7orf15,C7orf15MGC138295,CD112R,MGC104322,MGC138297,MGC2463,PVRIG,CD112 receptor

抗体購入プラットフォーム

プロジェクトステージタイプ由来疾患領域適応症
TIGIT&PVRIG BsAb - 01PCCMonoclonalHumanized MouseSolid TumorSolid tumor

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
COM-701COM-701Phase 2 ClinicalCompugen LtdBreast Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
詳細
PM-1009PM1009Phase 2 ClinicalCarcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Neoplasms; Solid tumours
詳細
SIM-0348SIM-0348Phase 1 ClinicalSimcere Pharmaceutical Group LtdNeoplasms; Solid tumours
詳細
GSK-4381562SRF-813; GSK-4381562; GSK-4381562A; GSK4381562A; GSK’562Phase 1 ClinicalSurface Oncology IncNeoplasms; Solid tumours
詳細
NM1FNM1F; TGI-2Phase 1 ClinicalHefei TG ImmunoPharma Co LtdColorectal Neoplasms; Melanoma; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
詳細
SHR-2002SHR-2002Phase 1 ClinicalShanghai Hengrui Pharmaceutical Co Ltd, Suzhou Suncadia Biopharmaceuticals Co LtdNeoplasms
詳細
JS-009JS009; TAB009; JS-009Phase 1 ClinicalShanghai Junshi Biosciences Co LtdNeoplasms; Solid tumours
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8